11 completed. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 11 |
Follow Hematologic Neoplasms: new trials by email Literature Review of Hematologic Neoplasms trials Research Report on Hematologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome Pegloticase, Rasburicase - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 4 | Completed | M.D. Anderson Cancer Center | 10 | 2022-04-05 | 2026-05-06 |
| Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults Biological samples - Kidney Transplant, Myeloma | Phase 4 | Completed | Centre Hospitalier Régional d'Orléans | 196 | 2021-03-26 | 2025-12-23 |
| Ketamine-ketorolac Versus Fentanyl- Ketorolac I.M in Children During Bone Marrow Biopsy ketamine-ketorolac, fentanyl- ketorolac - Hematological Malignancy (Leukemia- Lymphoma) | Phase 4 | Completed | Mansoura University | 80 | 2018-08-26 | 2020-09-09 |
| Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO Discontinuation of imipenem-cilastatin or meropenem - Febrile Neutropenia, Hematological Malignancy | Phase 4 | Completed | Amsterdam UMC, location VUmc | 276 | 2014-12-01 | 2019-09-25 |
| The Effect of Special Diets in Hematological Cancer Patients Special diet - Hematological Malignancy | Phase 4 | Completed | Jens Rikardt Andersen | 32 | 2013-11-01 | 2016-08-29 |
| A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area Posaconazole prophylaxis 120 mg/m² tid, Blood sampling - Hematological Malignancy | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 14 | 2012-02-01 | 2015-03-03 |
| A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing Prospective TDM Arm - Fungal Infection | Phase 4 | Completed | Johns Hopkins University | 29 | 2012-01-01 | 2016-08-18 |
| Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection Itraconazole - Invasive Fungal Infection | Phase 4 | Completed | Zhejiang University | 150 | 2008-07-01 | 2011-10-14 |
| Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) Busulfan, Fludarabine - Myelodysplastic Syndromes, Myeloproliferative Disorders | Phase 4 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 72 | 2005-08-01 | 2017-03-03 |
| A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation Drotrecogin Alfa (activated) - Sepsis, Hematologic Neoplasms | Phase 4 | Completed | Eli Lilly and Company | 7 | 2003-03-01 | 2007-12-07 |
| Intermittent Use of Aerosolized Ribavirin for Treatment of RSV Ribavirin - Hematological Malignancies | Phase 4 | Completed | M.D. Anderson Cancer Center | 51 | 2003-02-01 | 2012-08-01 |
Neoplasms (2) · Neoplasms, Plasma Cell (2) · Acquired Immunodeficiency Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Febrile Neutropenia (1) · Fever (1) · Hypergammaglobulinemia (1) · Infections (1) · Invasive Fungal Infections (1) · Leukemia, Lymphoid (1) · Lymphoma (1) · Multiple Sclerosis (1) · Mycoses (1) · Myelodysplastic Syndromes (1)
Hematologic Diseases (11) · Hemic and Lymphatic Diseases (11) · Neoplasms by Site (11) · Neoplasms (9) · Infections (4) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Pathological Conditions, Signs and Symptoms (3) · Bacterial Infections and Mycoses (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms by Histologic Type (2) · Signs and Symptoms (2) · Agranulocytosis (1) · Autoimmune Diseases (1)
Amides (1) · Blood Specimen Collection (1) · Busulfan (1) · Carbamates (1) · Cilastatin, Imipenem Drug Combination (1) · Itraconazole (1) · Meropenem (1) · Oxidoreductases (1) · Pegloticase (1) · Ribavirin (1) · Solutions (1) · Urate Oxidase (1) · Uric Acid (1) · Voriconazole (1) · drotrecogin alfa activated (1)
M.D. Anderson Cancer Center (2) · Amsterdam UMC, location VUmc (1) · Centre Hospitalier Régional d'Orléans (1) · Eli Lilly and Company (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Jens Rikardt Andersen (1) · Johns Hopkins University (1) · Mansoura University (1) · Universitaire Ziekenhuizen KU Leuven (1) · Zhejiang University (1)
United States (5) · Belgium (1) · China (1) · Denmark (1) · Egypt (1) · France (1) · Netherlands (1) · Romania (1)
Anca Colita, MD (1) · He Huang, MD (1) · Janelle Perkins, PharmD (1) · Jens Rikardt Andersen, MD,MPA (1) · Kieren Marr, MD (1) · Kim Vanstraelen, PharmD (1) · Mark MH Kramer, Prof., MD (1) · Michiel A van Agtmael, MD, PhD (1) · Roy F. Chemaly, MD (1) · Sonja Zweegman, Prof.,MD (1) · Sreedhar Mandayam, MD (1)
PMID 22198540, PMID 22927454, PMID 35691326, PMID 39115709
2014 (1)